<DOC>
	<DOCNO>NCT01835314</DOCNO>
	<brief_summary>Compassionate use Stiripentol Dravet Syndrome . This treatment protocol , research study , therefore child monitor clinical basis seizure improvement predominantly parent caregiver report .</brief_summary>
	<brief_title>Compassionate Use Stiripentol Dravet Syndrome</brief_title>
	<detailed_description>This treatment protocol compassionate use , research study , therefore child monitor clinical basis seizure improvement predominantly parent caregiver report .</detailed_description>
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Epilepsies , Myoclonic</mesh_term>
	<mesh_term>Stiripentol</mesh_term>
	<criteria>Children genetic confirmation Dravet syndrome ( documented sodium channel , voltagegated , type I , alpha subunit ( SCN1A ) mutation ) clinical confirmation Dravet syndrome two pediatric neurologist consider Dravet syndrome . In order enter treatment protocol document treatment failure least two therapeutic anticonvulsant exclude Na channel blocker . Anticonvulsants Na channel blocker carbamazepine lamotrigine know provoke seizures patient population .</criteria>
	<gender>All</gender>
	<minimum_age>1 Year</minimum_age>
	<maximum_age>21 Years</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>